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A B S T R A C T
Nowadays cataract surgery is refractive surgery as well. Intraocular lens implantation is gold standard, but there is
plenty types of intraocular lenses, monofocal, multifocal, accommodating, and toric. Problem is to pick up correct one ac-
cording life style, profession, health status and age. The aim is review current possibilities in cataract, refractive surgery
and aphakia management.
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Introduction
IOL technology has evolved dramatically in recent
years. Originally there was a replacement spherical lens
with only one optical function – compensating aphakia
but the function of modern IOL has changed and current
designs improve quality of vision – aberration correcting
IOL, filter inadequate wavelengths of light and compen-
sate for pseudophakic presbyopia- multifocal or accom-
modating IOL15. This is concept of premium IOLs.
Review of IOLs
Monofocal IOL
This is the most commonly used implant with the IOL
power chosen for seeing distant. For near vision, the pa-
tient requires reading glasses. The advantage of this IOL
is excellent clarity for distant vision.
Monofocal IOL has a fixed-range single focal point. It
has a fixed focusing power which is set for distant vision.
Recent refinements in the optical quality of these lenses
have allowed an even higher quality of vision than previ-
ously achievable. The materials of IOL are hydrophilic
acrylate, hydrophobic acrylate, silicon and their combi-
nation. The most important is design of IOL – square
edge, which prevents capsular opacification. Some of
them have excellent optical clarity which minimizes
problems of internal reflections associated with any IOL
implanted in the eye with its anti-glare technology. As
such, this IOL would be suitable for patients who suffer
from glare during the day. Premium IOLs can be divided
into aspheric, toric, presbyopia correcting IOLs and their
combination. A good IOL design allows the surgeon to
adapt vision to the patient’s lifestyle.
Monofocal Aspheric IOL
Offer the best in optical innovation: a high-quality im-
age and enhanced contrast perception during all daily ac-
tivities, whatever the lighting conditions may be. Aspheric
intraocular lenses Aspheric lenses allow you to achieve a
visual performance that is close to that of a young per-
son's eye
Toric IOL
Advancements in IOL design have led to the develop-
ment of toric spherical and aspherical IOLs and multi-
focal toric IOLfor the treating pre-existing corneal astig-
matism during refractive cataract surgery. With accurate
preoperative planning and patient selection, a toric IOL
can be a precise and effective option for treating astigma-
tism. Furthermore, the introduction of toric IOLs into
practice can be an easy way to enter the premium IOL
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market1. The most important is good axis stability. Toric
IOLs’ powers range from –1.50D to –3.00D, giving them
an effective power of up to –2.00D at the corneal plane.
Higher amounts of astigmatism can be managed with
limbal relaxing incisions. Accurate corneal cylinder mea-
surements are required, either through keratometry or
IOL Master measurement. Patients whose astigmatism
is less than 1.25D can have it corrected with the place-
ment of the incisions. Patients who might not be as suc-
cessful with a toric IOL are those who have an unstable
capsular bag or demonstrate pseudo exfoliation and/or
weak zonules. In these patients, the lens may rotate once
implanted, altering the patient’s vision.
Multifocal IOL
This IOL is designed to solve the problem of focusing
for near after cataract extraction so that the patient does
not need reading glasses. The main problem with this
IOL is that there is an average reduction in contrast sen-
sitivity between 30–50% depending on how much light is
weighted for near and how much for distance. There is
also the problem of glare and haloes due to the multiple
concentric focusing powers within the IOL8,9. However,
the intermediate vision remains slightly out of focus.
Multifocal IOL has specialized optical properties that
can divide light to bring it into focus at more than one
point at the same time. This IOL is designed with con-
centric rings which can focus light rays from both dis-
tance and near simultaneously. The optics of modern
multifocal IOLs is either rotationally symmetric or rota-
tionally asymmetric. Some multifocal IOLs modify the
index of refraction, from the peripheral to the central
part of the lens, so that the lens optical power changes
depending on pupil size3,4. Other presbyopia correcting
IOL work by introducing asphericity or removing chro-
matic aberration from the lens optics to improve near
and intermediate vision. For multifocal IOL to work effi-
ciently, astigmatism must be completely eliminated. In
most cases, multifocal IOLs induce a loss of contrast sen-
sitivity and are therefore contraindicated in eyes with
aberrated corneas or in patients with limited contrast
sensitivity such as those with maculopathy, retinal dys-
trophy, glaucoma, or advance senility12.
Perfect multifocal IOL must exhibits following optical
and design principles2:
1. Focus dominant for far vision
2. Adequate disparity between near and far foci
3. Aspheric design
4. Available toric model
5. Pupil independent mechanism
6. Good optical performance on the optical bench in
vivo
7. Good capsular stability
8. Low rate of posterior capsular opacification
9. Implantable through micro incision
10. Demonstration of good visual outcomes for far and
adequate outcomes for intermediate and near vision
that can be adapted to the lifestyle of the patient.
How we can achieve patient satisfaction with pre-
mium IOLs?
• Deliver well near vision. Patients must be able to
read newspapers and books, at least in good
light.
• We must know patient’s need for intermediate vi-
sion.
• We must clarify to the patient that optical side ef-
fects are common
• We must explain to the patient that neural adapta-
tion is a process
• Astigmatism must be corrected in multifocal IOL if
the patient has more than 0,5D of astigmatism
• In some cases we must perform IOL exchange
• We must learn how to identify ideal candidates,
mostly best one is hyperopic (2D or more) or hyper-
opic astigmatism. The second best is high myopic
patient (–6D or more)
Patients should know that their visual quality will be-
come more dependent on light conditions, that they will
need a period of adaptation, and that eventually they
might not achieve complete spectacle independence, but
more likely partial spectacle independence. On average,
distance visions of 20/25 and near vision of J2 are achie-
ved by 80% of multifocal IOL patients.
The principle side effects of diffractive lenses are
glare and halo, secondary to the two light foci within the
eye. And, these lenses cause a reduction in contrast sen-
sitivity as a result of the separation in light energy into
the two bundles11. When comparing the contrast sensi-
tivity of these IOLs to a monofocal control, there are
measurable differences in contrast sensitivity between
the two groups at higher spatial frequencies under both
photopic and mesopic conditions. With diffractive optics,
41% of light energy is dispersed to the near image, and
41% of light energy is dispersed to the distance image.
This leaves 18% of non- functional light5. Keep in mind
that the human eye is not accustomed to processing mul-
tiple images, so it may take time for it to adapt to a
diffractive lens. This process can take anywhere from
weeks to a year. The incidence of dysphotopsias, however,
differed drastically when patients were directly asked
about it (20 to 77%) or asked to self-report it in the event
that they manifested (0.2 to 1.5%)6. It has been found
that younger patients, patients without maculopathy
and patients with better convergence are more likely to
neuroadaptation8,9.
Triphocal IOL
These IOLs provides high patient satisfaction to pres-
byopic patients with increased safety7. It provides an ex-
cellent optical performance at all distances in all light
conditions. Nowadays there is only one IOL in the mar-
ket: AT LISA multifocal IOL13,14.
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The Benefit – LISA
Light distributed asymmetrically between distant
(65%) and near focus (35%) for improved intermediate
vision and greatly reduced halos and glare
Independency from pupil size due to high perfor-
mance diffractive-refractive microstructure covering the
complete 6.0 mm optical diameter
SMP technology for a lens surface without any sharp
angles for ideal optical imaging quality with reduced
light scattering
Aberration correcting optimized aspheric optic for
better contrast sensitivity, depth of field and sharper vi-
sion
New IOL with trifocal optic enables spectacles inde-
pendence and good vision at all distances, including in-
termediate space. IOL has +3,5D addition for near vision
and +1,75D for intermediate vision and far focus for dis-
tance vision. Loss of light is reduced to 14% and there is
no drop in visual acuity at any distance. Intermediate vi-
sion is good and sharp vision at distance and near is
maintained. Design of IOL is aspheric with blue blocking
filter. AT LISA tri 839MP is aspheric micro incision IOL.
Principles of construction are light distribution asym-
metrically, independency from pupil size, SMP technol-
ogy for ideal optical imaging quality with reduced light
scattering and aberration-correcting optimized aspheric
optic for better contrast sensitivity, depth of field and
sharper vision. Light distribution is 50% for far, 20% for
intermediate and 30% for near. Other advantages are im-
proved intermediate vision with 1,66D intermediate ad-
dition. The lens has refractive-diffractive profile increas-
ing light transmittance to approximately 85,5%. Fewer
rings on the optical surface IOL reduces the risk for vi-
sual disturbances and improved night vision. High reso-
lution in all lighting condition, there are maximum pupil
independence up to 4.5 mm
Accommodating IOL
The accommodating IOLs have several unique fea-
tures. The haptic on the lens acts as a »hinge« to allow
the lens to move slightly forward and flex secondary to
vitreous pressure during accommodation. The optic of
the lens moves forward with the contraction of the ciliary
muscle through an increase in vitreous cavity pressure.
Also, the lens »arches« centrally, which increases nega-
tive spherical aberrations and coma. Additionally, the
central asphericity of the IOL increases depth of focus,
providing improved near vision. In order to achieve a
»flexing« of the lens, it must sit completely posterior
within the capsular bag. If it sits differently, the distance
prescription may be impacted, and also, the lens may not
move forward enough to achieve good near vision10.
Patients’ Selections
These options can be confusing to patients, but it is
important that they are aware of the lenses available.
Steven Dell, M.D., has developed a survey to help pa-
tients understand that none of the lenses can provide
»everything«.
This tool, or something like it, can help patients un-
derstand if their day-to-day lives require more distance,
intermediate or near vision. The survey also helps you
understand which patients are more or less likely to
neuroadapt to multifocal IOLs. Such tools can help direct
the conversation with cataract surgery patients about
premium IOLs.
Several factors determine the IOL that best suits each
patient. These include the patient’s age, occupation, hob-
bies, daily activities, pupil size and retinal health. Pupil
size is also important to consider. Patients with very
small pupils (less than 3.5 mm) may not benefit from the
full effect of the diffractive optics, and those patients
with large pupils (greater than 7mm) may have increased
glare and halo when implanted with diffractive lenses.
Because these patients are paying a premium for these
lenses, their demands for high-quality vision can be
greater than those of the »average« cataract patient. The
tear layer can also affect vision. Evaluating the tear layer
should be part of the normal preoperative evaluation.
When necessary, treating ocular surface disease before
surgery improves the quality of vision after surgery. That
treatment can include artificial tears, cyclosporine, hot
compresses, fish oil pills and punctual occlusion. A pa-
tient’s motivation to be free of glasses is also an impor-
tant factor to evaluate. Some patients are very happy
with glasses and are almost fearful to be without them.
While spectacle dependence is minimized with all pre-
mium IOLs, complete independence cannot be expected
with any of them, and none of the lenses accommodate as
easily as a 25-year-old’s eye. It is crucial to counsel pa-
tients as to the strengths and limitations of the different
options. In general, patients who prefer close vision over
intermediate vision will be happier with a diffractive
lens. Those who are concerned about glare and are will-
ing to use reading glasses as needed, will be happier with
accommodating IOL. Of course, each patient needs to be
treated individually. It is key to ask each patient the
same list of questions: glare, acceptability of glasses for
near work, etc. You will find there is only a small subset
of answers.
Supplementary IOL
IOLs are design for refractive surprises after cataract
surgery. There are many types, spheric, aspheric, multi-
focal, and toric and design for implantation in sulcus.
Photo chromatic IOL
Special intraocular lenses »Aurium« react quickly on
light, its color change in 10 second in yellow and back to
clear in 30 seconds.
Light Adjustable IOL
The unique molecular composition of the Light Ad-
justable Lens (LAL, Calhoun Vision) enables customized
power and wavefront adjustment after implantation. It is
good for straightforward correction of sphere and cylin-
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der, to correct residual refractive errors following corneal
refractive surgery, for customized near add and adjust-
able monovision. IOL can be adjusted postoperatively to
correct for higher-order aberrations and common post-
surgical refractive errors – a boon in this age of demand-
ing patients with high expectations. This IOL has the po-
tential to provide customized correction for each indi-
vidual eye.
How It Works
Silicone IOLs have spaces on a molecular level within
the IOL. In the LAL, these spaces are filled with light-
-sensitive, free-floating macromolecules, If the right wave-
length of light hits one of the macromolecules, it will at-
tach to the silicone, and what’s left will redistribute itself
and reshape the IOL. Specifically, the free-moving photo-
sensitive macromolecules are fixed in place through poly-
merization when the surgeon shines UV light in the near
range (365 nm) on the lens. When some of the macromo-
lecules are polymerized, the remaining macromolecules
redistribute through the lens, changing its shape and re-
fractive power. The UV light is delivered with a digital
light delivery device, made by Carl Zeiss Meditec. This al-
lows a precise pattern on the lens that can be controlled.
As a result, the LAL can be customized to treat spherical,
cylindrical and other higher-order aberrations as well as
to create refractive multifocality and diffractive bifoca-
lity. If the IOL is decentred a little from the optical axis,
then the effect drops dramatically. But with the LAL, you
can actually correct on the axis.«
Phakic IOL
Was effective in the correction of moderate to high
myopia and provided excellent visual performance with
no modification of physiologic ocular wavefront error.
Adequate distance from the cornea and crystalline lens
was maintained with no significant change during fol-
low-up and under different environmental conditions.
There are anterior chamber IOLs and posterior contact
IOLs.
Violet and blue light blocking IOL
Optical radiation includes ultraviolet (UV) radiation
(200–400 nm) and visible light (400–700 nm). Violet
(400–440 nm) and blue (440–500 nm) light comprise the
shorter wavelength part of the visible spectrum.2,3 The
cornea prevents UV radiation shorter than 300 nm from
reaching the retina. The crystalline lens blocks most UV
between 300 nm and 400 nm. Light transmission by the
crystalline lens decreases with ageing, particularly at
shorter wavelengths. The first poly(methylmethacrylate)
intraocular lenses (IOLs) transmitted UV in addition to
visible light. UV does not provide useful vision but it can
harm the retina in acute intense exposures. Most IOLs
incorporated UV blocking chromophores by year 1986.
Interest in blocking visible light as well as UV is moti-
vated by the unproved hypothesis that phototoxicity
from environmental light exposure can cause or acceler-
ate age related macular degeneration (AMD)16. This pho-
totoxicity – AMD hypothesis is popular in part because
lipofuscin accumulates with ageing in the retinal pig-
ment epithelium (RPE), perhaps increasing the retinal
phototoxicity risks of older adults. But none the less, six
of the eight major epidemiological studies found no cor-
relation between AMD and lifelong light exposure, cau-
sed by its absence, difficulty in accurately estimating a
subject’s cumulative light exposure retrospectively, vari-
ability in genetic susceptibility, or other potentially ob-
fuscating factors such as differences in the age at which
subjects experience bright environmental light exposure.
Light can damage the retina by photomechanical,
photothermal, or photochemical mechanisms.We know
the two classic types of acute retinal photochemical inju-
ries (»photic retinopathies« or »retinal phototoxicities«).
The first type of phototoxicity is blue-green (»Noell-ty-
pe,« »class 1,« or »white light«) photic retinopathy. Its ac-
tion spectrum is similar to aphakic scotopic sensitivity
because rhodopsin mediates both processes. Thus, blue-
-green phototoxicity hazardousness actually decreases in
the blue and violet part of the spectrum below rhodop-
sin’s peak sensitivity around 500 nm. Furthermore, any
spectral filter that reduces blue-green phototoxicity cau-
ses an equivalent percentage decrease in scotopic sensi-
tivity.
The second type of phototoxicity is UV-blue (»Ham-
-type,« »class 2,« or »blue light hazard«) photic retino-
pathy. Its severity increases with decreasing wavelength,
similar to that of lipofuscin which is one of its primary
mediators. The macular xanthophyll protection declines
rapidly in the violet part of the spectrum, where por-
phyrin and cytochrome oxidase phototoxicity peak. The
weakly phototoxic pyridinium bisretinoid A2E compo-
nent of lipofuscin also has peak phototoxicity around 430
nm in the violet part of the spectrum. Separating acute
photic retinopathy into the two preceding categories is
useful heuristically, but it may oversimplify phototoxic
interactions currently used to study retinal degeneration
and cell biology. Acute UV-blue and lipofuscin photo-
toxicity rise rapidly in the violet part of the spectrum,
where porphyrin and cytochrome oxidase phototoxicities
peak and macular xanthophyll protection declines.
There are three types of retinal photopigments: cone
photoreceptor photopigments that provide photopic
(bright light) and mesopic (intermediate light) vision,
rhodopsin in rod photoreceptors responsible for mesopic
and scotopic (dim light) vision, and melanopsin in blue
light sensitive retinal ganglion cells that modulate circa-
dian photoentrainment, pupillary function, and possibly
conscious vision. IOLs that block UV and visible light po-
tentially reduce the risk of acute UV-blue phototoxicity.
They also decrease the light reaching S-cones, light sen-
sitive retinal ganglions, and rod photoreceptors, which
have peak spectral sensitivities around 426 nm (violet),
480 nm (blue), and 500 nm (blue-green), respectively.
Melanopsin containing light sensitive retinal ganglion
cells control circadian photoentrainment through mela-
tonin suppression. Melatonin suppression has peak sen-
S. Svatopluk: The Latest Generation of Intraocular Lenses, Coll. Antropol. 37 (2013) Suppl. 1: 217–221
220
U:\coll-antropolo\coll-antro-(Suppl 1)-2013\P21 Svatopluk.vp
2. travanj 2013 16:58:52
Color profile: Generic CMYK printer profile
Composite  150 lpi at 45 degrees
sitivity in human subjects of roughly 460 nm (blue), ap-
proximately 20 nm shorter than the peak sensitivity
measured experimentally for the photopigment melano-
psin. The action spectra for acute experimental blue-
-green and UV-blue phototoxicities are well character-
ised, but if there is chronic light damage in humans, its
action spectrum is unknown. If the phototoxicity-AMD
hypothesis is valid and chronic retinal damage arising
from lifelong repetitive acute phototoxic injury does have
a significant role in AMD, then action spectra for the two
classic types of photic retinopathy can be used to esti-
mate the relative protection afforded by different IOL
spectral filters. UV-blue phototoxicity is characterised by
the international standard aphakic retinal hazard func-
tion based on Ham’s studies of light damage in young
primates. Blue-green phototoxicity may be specified by
the aphakic scotopic sensitivity function governed by
rhodopsin light absorption. Retinal photoprotection, sco-
topic sensitivity, and circadian photoentrainment rela-
tive to a conventional UV only blocking IOL were com-
puted for: hypothetical UV + violet blocking high pass
filters that have different cut-off wavelengths, UV + vio-
let and UV + violet + blue blocking IOLs, and crystalline
lenses of different ages, using spectral data for acute
UV-blue retinal phototoxicity, aphakic scotopic luminous
efficiency, melanopsin sensitivity, and melatonin sup-
pression, transmittance spectra measured for each IOL,
and published data on the spectral transmittance of crys-
talline lenses and sunglasses. The terms »violet block-
ing« and »blue blocking« will be used for IOLs that atten-
uate UV + violet and UV + violet + blue light, respec-
tively. Action spectra for most retinal photosensitisers in-
crease in the violet part of the spectrum. Melanopsin,
melatonin suppression, and rhodopsin sensitivities are
all maximal in the blue part of the spectrum. Scotopic
sensitivity and circadian photoentrainment decline with
ageing. UV blocking IOLs provide older adults with the
best possible rhodopsin and melanopsin sensitivity. Blue
and violet blocking IOLs provide less photoprotection
than middle aged crystalline lenses, which do not pre-
vent age related macular degeneration (AMD). Thus,
pseudophakes should wear sunglasses in bright environ-
ments if the unproved phototoxicity-AMD hypothesis is
valid.
Conclusion
Author summarized current possibilities in intraocu-
lar lens implantation after lens surgery. The most impor-
tant is individual approach to our clients and arts to lis-
ten all their demands.
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POSLJEDNJA GENERACIJA INTRAOKULARNIH LE]A I PROBLEM U REFRAKCIJI OKA NAKON
OPERACIJE KATARAKTE
S A @ E T A K
U dana{nje vrijem kirurgija katarakte ujedno je i refraktivna kirurgija. Autor navodi razne tipove intraokularnih le}a u
korekciji monofokalno, multifokalno i torik. Prodlem je odabrati adekvatan tip le}e obzirom na profesiju i starost paci-
jenta.
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